Pangaea Oncology financials at a glance

The revenue of Pangaea Oncology is reported as 0.00437 billion Euro in the fiscal year 2023. The earnings were -0.03 Euro per share in 2023, which was 70 higher than 2020. And about -0.00375 billion Euro are reported as free cash flow in the financials of Pangaea Oncology 2023. No dividends were paid to the shareholders of the Pangaea Oncology stock BME:PANG in the financial year 2023.